Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.
A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...
[JONAH ONYANGO/STANDARD.] A nationwide shortage of Bacillus Calmette-Guerin (BCG) vaccines in the country leaves Kenyan newborns vulnerable to Tuberculosis (TB), a disease with a high prevalence ...
Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...
The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.
The Star Worldwide (English) on MSN2h
HENNET links vaccine stock-out to reduced budgetHealth Non-Governmental Organisations Network (HENNET) has blamed low budgetary allocation for the recurring vaccine ...
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...
Zacks.com on MSN7d
Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer StudyData from a late-stage study shows that treatment with PFE's PD-1 inhibitor when added to BCG improves outcomes in certain ...
News Medical on MSN10d
Self-Destructing TB Vaccine Boosts Monkey ImmunityA self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback